Investors considering a purchase of Harrow Inc (Symbol: HROW) stock, but tentative about paying the going market price of $35.48/share, might benefit from considering selling puts among the ...
Harrow, Inc. is an ophthalmology company with strong revenue growth, ambitious targets, and a diverse product portfolio including Vevye and Iheezo. HROW targets $280M in 2025 revenue and >$250M per ...
The London Borough of Harrow has launched a new digital twin enabling remote building inspections and more immersive online experiences for citizens. High resolution drone imagery is allowing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results